Alemtuzumab and Pentostatin In T-cell Neoplasms
Clinical trial NCT00453193 · TERMINATED
Trial details
- NCT number
- NCT00453193
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2010-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.